Changes in the V3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Δ32 heterozygote

被引:33
|
作者
Gorry, Paul R.
Dunfee, Rebecca L.
Mefford, Megan E.
Kunstman, Kevin
Morgan, Tom
Moore, John P.
Mascola, John R.
Agopian, Kristin
Holm, Geoffrey H.
Mehle, Andrew
Taylor, Joann
Farzan, Michael
Wang, Hui
Ellery, Philip
Willey, Samantha J.
Clapham, Paul R.
Wolinsky, Steven M.
Crowe, Suzanne M.
Gabuzda, Dana
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[4] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[5] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[6] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[7] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia
[8] Monash Univ, Dept Med, Clayton, Vic 3168, Australia
[9] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Program Mol Med, Worcester, MA 01655 USA
关键词
HIV-1; CCR5; Delta; 32; ENV; V3;
D O I
10.1016/j.virol.2006.11.025
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Heterozygosity for the CCR5 Delta 32 allele is associated with delayed progression to AIDS in human immunodeficiency virus type 1 (HIV-1) infection. Here we describe an unusual HIV-1 isolate from the blood of an asymptomatic individual who was heterozygous for the CCR5 Delta 32 allele and had reduced levels of CCR5 expression. The primary virus used CCR5, CXCR4, and an unusually broad range of alternative coreceptors to enter transfected cells. However, only CXCR4 and CCR5 were Used to enter primary T cells and monocyte-derived macrophages, respectively. Full-length Env clones had an unusually long V1/V2 region and rare amino acid variants in the V3 and C4 regions. Mutagenesis studies and structural models suggested that Y308, D321, and to a lesser extent K442 and E444, contribute to the broad coreceptor usage of these Envs, whereas 1317 is likely to be a compensatory change. Furthermore, database analysis suggests that covariation can occur at positions 308/317 and 308/321 in vivo. Y308 and D321 reduced dependence on the extracellular loop 2 (ECL2) region of CCR5, while these residues along with Y330, K442, and E444 enhanced dependence on the CCR5 N-terminus compared to clade B consensus residues at these positions. These results suggest that expanded coreceptor usage of HIV-1 can occur in some individuals without rapid progression to AIDS as a consequence of changes in the V3 region that reduce dependence on the ECL2 region of CCR5 by enhancing interactions with conserved structural elements in G-protein-coupled receptors. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:163 / 178
页数:16
相关论文
共 50 条
  • [31] Molecular modeling of the V3 loop of HIV-1 gp120.
    Janicka, A
    Svetcov, C
    Parish, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U710 - U710
  • [32] CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
    Wang, WK
    Dudek, T
    Zhao, YJ
    Brumblay, HG
    Essex, M
    Lee, TH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5740 - 5745
  • [33] Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor
    Suphaphiphat, Pirada
    Essex, Max
    Lee, Tun-Hou
    VIROLOGY, 2007, 360 (01) : 182 - 190
  • [34] HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc
    Garg, Himanshu
    Lee, Raphael T. C.
    Maurer-Stroh, Sebastian
    Joshi, Anjali
    VIROLOGY, 2016, 493 : 86 - 99
  • [35] Analysis of the HIV-1 gp120 V3 loop at screening for treatment-experienced patients in the MOTIVATE studies who failed with CCR5 tropic virus
    Lewis, M.
    Simpson, P.
    Jubb, B.
    Craig, C.
    Valdez, H.
    Westby, M.
    ANTIVIRAL THERAPY, 2010, 15 : A76 - A76
  • [36] Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
    Lu, ZH
    Berson, JF
    Chen, YH
    Turner, JD
    Zhang, TY
    Sharron, M
    Jenks, MH
    Wang, ZX
    Kim, J
    Rucker, J
    Hoxie, JA
    Peiper, SC
    Doms, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6426 - 6431
  • [37] Viraemic control and viral coreceptor usage in two HIV-1-infected homozygous CCR5 Δ32 individuals
    Henrich, T.
    Hanhauser, E.
    Stellbrink, H-J
    Noah, C.
    Martin, J.
    Deeks, S.
    Kuritzkes, D.
    Pereyra, F.
    ANTIVIRAL THERAPY, 2013, 18 : A16 - A16
  • [38] R5 HIV-1 gp120 Activates p38 MAPK to Induce Rat Cardiomyocyte Injury by the CCR5 Coreceptor
    Gao, Rui
    Fang, Qiujuan
    Zhang, Xi
    Xu, Qin
    Ye, Hanhui
    Guo, Wenyan
    He, Jiao
    Chen, Yahong
    Wang, Ruixing
    Wu, Zhijuan
    Yu, Jing
    PATHOBIOLOGY, 2019, 86 (5-6) : 274 - 284
  • [39] Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32
    Henrich, Timothy J.
    Hanhauser, Emily
    Hu, Zixin
    Stellbrink, Hans-Juergen
    Noah, Christian
    Martin, Jeffrey N.
    Deeks, Steven G.
    Kuritzkes, Daniel R.
    Pereyra, Florencia
    AIDS, 2015, 29 (08) : 867 - 876
  • [40] V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY
    IVANOFF, LA
    DUBAY, JW
    MORRIS, JF
    ROBERTS, SJ
    GUTSHALL, L
    STERNBERG, EJ
    HUNTER, E
    MATTHEWS, TJ
    PETTEWAY, SR
    VIROLOGY, 1992, 187 (02) : 423 - 432